Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. J. WOLBINK
Immunogenicity Negatively Influences the Outcome of Adalimumab Treatment in Crohn’s Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Perspectives in Crohn’s Disease
Digestion
Gastroenterology
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Mycobacterial Infection Influences Bone Biomarker Levels in Crohn’s Disease
Canadian Journal of Physiology and Pharmacology
Medicine
Physiology
Pharmacology
Primary Cutaneous Nocardiosis in a Patient Taking Adalimumab Therapy for Crohn’s Disease
Kansas Journal of Medicine
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Certolizumab Pegol for the Treatment of Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial
Gastroenterology
Hepatology
Gastroenterology
Dietary Treatment of Active Crohn’s Disease
Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Medicine
